|
|
Volumn 11, Issue 2, 2014, Pages 63-
|
|
Dyslipidaemia: 1-Year results from OSLER trial of anti-PCSK9 monoclonal antibody evolocumab
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EVOLOCUMAB;
HIGH DENSITY LIPOPROTEIN CHOLESTEROL;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
TRIACYLGLYCEROL;
CHOLESTEROL BLOOD LEVEL;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
HYPERCHOLESTEROLEMIA;
INJECTION SITE REACTION;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
SHORT SURVEY;
TRIACYLGLYCEROL BLOOD LEVEL;
ANTIBODIES, MONOCLONAL;
FEMALE;
HUMANS;
HYPERCHOLESTEROLEMIA;
MALE;
|
|
EID: 84893706591
PISSN: 17595002
EISSN: 17595010
Source Type: Journal
DOI: 10.1038/nrcardio.2013.201 Document Type: Short Survey |
|
Times cited : (6)
|
|
References (0)
|
